Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Draganfly (DPRO) unveils Vital Intelligence Smart Vital Kiosk at the CES 2022 in Las Vegas
  • Smart Vital Kiosk can screen temperature, blood pressure, heart rate, respiratory rate, and oxygen saturation
  • Smart Vital Kiosk is part of Draganfly’s Vital Intelligence health and safety solution which is able to screen, detect, access and provide continuous action against the potential threat of infectious diseases, such as COVID-19
  • Draganfly (DPRO) is down 4.07 per cent at C$2.12 per share at 2:08 PM EST

Draganfly (DPRO) has unveiled the Vital Intelligence Smart Vital Kiosk at the CES 2022 in Las Vegas.

The Smart Vital Kiosk can screen body temperature, blood pressure, heart rate, respiratory rate, and oxygen saturation. The system does not register any personal data of the individual being screened.

The Smart Vital Kiosk is powered by Draganfly’s Vital Intelligence platform.

This Smart Vital system is part of Draganfly’s Vital Intelligence health and safety solution, which is able to screen, detect, access and provide continuous action against the potential threat of infectious diseases, such as COVID-19.

The Smart Vital Kiosk’s LCD screen is accessible, according to the Americans with Disabilities Act and its infrared thermal camera adheres to Food and Drug Administration’s guidelines.

Paul Mullen, Vice President of Vital Intelligence at Draganfly remarked on the Smart Vital Kiosk.

“We are committed to providing seamless and non-invasive solutions that allow organizations to host safe events and gatherings. Utilizing proprietary software built by Draganfly, the new Smart Vital Kiosk enables multi-dimensional screening of core vitals to provide real-time health insights in seconds.”

Draganfly is a corporation focusing on drone solutions, software and AI systems in regards to public safety, agriculture, and security.

Draganfly (DPRO) is down 4.07 per cent at C$2.12 per share at 2:08 PM EST.

More From The Market Herald

" Medicenna (TSX:MDNA) announces publication of MDNA11 preclinical data

Medicenna Therapeutics Corp. (MDNA) announced the publication of preclinical data on MDNA11.

" Clearmind Medicine (CSE:CMND) engages the Independent Trading Group as a market maker and Thunder11 as a PR agency

Clearmind Medicine Inc. (CMND) has engaged the services of Independent Trading Group to provide market-making services.

" Psyched Wellness (CSE:PSYC) provides update on study with the National Research Council of Canada

Psyched Wellness (PSYC) has released preliminary data from its study with the National Research Council of Canada (NRC).
codikoat, covid protection

" PharmaDrug (CSE:PHRX) begins manufacturing PD-001 for treatment of rare cancers and COVID-19

PharmaDrug (PHRX) has begun manufacturing PD-001, its oral formulation of cepharanthine, for cancer and infectious disease studies.